{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-014952","form_type":"8-K","ticker":"NXTS","cik":"0001789192","company_name":"Nexentis Technologies Inc.","filed_at":"2025-09-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.001162+00:00","generated_at":"2026-05-17T05:40:58.492876+00:00","sec_items":["5.07","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"N2OFF shareholders approve acquisition of MitoCareX Bio; closing targeted by early Oct 2025","bullets":["Stockholders voted 11.7M for, 197K against to approve the MitoCareX acquisition; reverse split and warrant share proposals also passed.","N2OFF will acquire MitoCareX from SciSparc (SPRC) and others for $700K plus shares equal to 40% of fully diluted stock.","Sellers get 30% of financing proceeds (capped at $1.6M) for 5 years and milestone issuances up to 25% of common stock.","N2OFF commits an initial $1M cash investment to support MitoCareX operations for two years post-closing.","A 1-for-35 reverse stock split was already effected on Sept 22; the approved split range (1:2 to 1:150) allows further action within one year."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-014952","json":"https://secwatch.observer/filing/0001493152-25-014952.json","markdown":"https://secwatch.observer/filing/0001493152-25-014952.md","text":"https://secwatch.observer/filing/0001493152-25-014952.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1789192/000149315225014952/0001493152-25-014952-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1789192/000149315225014952/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:40:58.492876+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}